The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation
Abstract
Objective: Differentiation of oligodendroglial precursor cells is crucial for central nervous system remyelination and is influenced by both extrinsic and intrinsic factors. Recent studies showed that human endogenous retrovirus type W (HERV‐W) contributes significantly to brain damage. In particular, its envelope protein ENV can mediate injury to specific cell types of the brain and immune system. Here, we investigated whether ENV protein affects oligodendroglial differentiation. Methods: Immunostaining and gene expression analyses were performed to establish the expression and regulation of the known ENV receptor, Toll‐like receptor 4 (TLR4), on oligodendroglial precursor cells in human brain tissue and in culture. Cultured primary oligodendroglial precursor cells were stimulated with ENV protein to determine the effects of this ligand/receptor interaction. Results: We demonstrated that the ENV protein is present in close proximity to TLR4‐expressing oligodendroglial precursor cells adjacent to multiple sclerosis lesions. Human and rat oligodendroglial precursor cells expressed TLR4, and the ENV‐mediated activation of TLR4 led to the induction of proinflammatory cytokines and inducible nitric oxide synthase as well as the formation of nitrotyrosine groups and a subsequent reduction in myelin protein expression. Interpretation: Our findings suggest that ENV‐mediated induction of nitrosative stress via activation of TLR4 results in an overall reduction of the oligodendroglial differentiation capacity, thereby contributing to remyelination failure. Therefore, pharmacological or antibody‐mediated inhibition of ENV may prevent the blockade of myelin repair in the diseased or injured central nervous system. Ann Neurol 2013;74:721–732
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several exogenous and endogenous viruses have been considered in MS pathogenesis, with the most compelling evidence implicating respectively Epstein-Barr virus (EBV)40 and human endogenous retrovirus type-W (HERV-W)41.”
From Locus for severity implicates CNS resilience in progression of multiple sclerosis (2023) · cites this paper as [41]
Citations
Cites
Takeda, K., & Akira, S. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.003 · Cited by 2,528
Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis
Mi, S., Lee, X., Li, X., Veldman, G. M., Finnerty, H. F., Collins‐Racie, L. A., LaVallie, E. R., Tang, X.-Y., Edouard, P., Howes, S., et al. (2000) · Nature · doi:10.1038/35001608 · Cited by 1,711
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991
Endogenous viruses: insights into viral evolution and impact on host biology
Feschotte, C., & Gilbert, C. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3199 · Cited by 918
Kuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
Noble, M., Murray, K., Stroobant, P., Waterfield, M. D., & Riddle, P. (1988) · Nature · doi:10.1038/333560a0 · Cited by 830
Regulation of protein function by S‐glutathiolation in response to oxidative and nitrosative stress
Klatt, P., & Lamas, S. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01601.x · Cited by 757
NG2-Positive Oligodendrocyte Progenitor Cells in Adult Human Brain and Multiple Sclerosis Lesions
Chang, A., Nishiyama, A., Peterson, J. W., Prineas, J. W., & Trapp, B. D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06404.2000 · Cited by 711
Bolaños, J. P., Almeida, Á., Stewart, V. C., Peuchen, S., Land, J. M., Clark, J. B., & Heales, S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062227.x · Cited by 519
Flagged first, then by citations
1 of the 50 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Regulatory activities of transposable elements: from conflicts to benefits
Chuong, E. B., Elde, N. C., & Feschotte, C. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.139 · Cited by 1,408
Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses
Grandi, N., & Tramontano, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02039 · Cited by 354
Tam, O. H., Rozhkov, N. V., Shaw, R., Kim, D., Hubbard, I., Fennessey, S., Propp, N., Phatnani, H., Kwan, J., Sareen, D., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.066 · Cited by 327
Human Endogenous Retroviruses in Neurological Diseases
Küry, P., Nath, A., Créange, A., Dolei, A., Marche, P. N., Gold, J., Giovannoni, G., Hartung, H., & Perron, H. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.02.007 · Cited by 300
Self-citationLocus for severity implicates CNS resilience in progression of multiple sclerosis
International Multiple Sclerosis Genetics Consortium, Harroud, A., Stridh, P., McCauley, J. L., Saarela, J., van den Bosch, A. M. R., Engelenburg, H. J., Beecham, A. H., Alfredsson, L., Alikhani, K., et al. (2023) · Nature · doi:10.1038/s41586-023-06250-x · Cited by 243
HERV Envelope Proteins: Physiological Role and Pathogenic Potential in Cancer and Autoimmunity
Grandi, N., & Tramontano, E. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00462 · Cited by 233
Zhang, J., Buller, B., Zhang, Z. G., Zhang, Y., Lü, M., Rosene, D. L., Medalla, M., Moore, T. L., & Chopp, M. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113895 · Cited by 196
Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?
Ettle, B., Schlachetzki, J. C. M., & Winkler, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9205-3 · Cited by 160
Zivadinov, R., Guan, Y., Jakimovski, D., Ramanathan, M. K., & Weinstock‐Guttman, B. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.245462 · Cited by 150
Epigenetics of Multiple Sclerosis: An Updated Review
Küçükali, C. İ., Kürtüncü, M., Çoban, A., Çebi, M., & Tüzün, E. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8298-6 · Cited by 141
Kremer, D., Gruchot, J., Weyers, V., Oldemeier, L., Göttle, P., Healy, L. M., Jang, J. H., Xu, Y. K. T., Volsko, C. M., Dutta, R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901283116 · Cited by 121
Self-citationTLR4 is a link between diabetes and Alzheimer’s disease
Huang, N., Jin, H. D., Zhou, S., Shi, J., & Jin, F. J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.047 · Cited by 122
Perron, H., Dougier, H.-L., Lomparski, C., Popa, I., Firouzi, R., Bertrand, J., Marušić, S., Portoukalian, J., Jouvin‐Marche, E., VILLIERS, C. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080128 · Cited by 119
Self-citationMorandi, E., Tănăsescu, R., Tarlinton, R. E., Constantinescu, C. S., Zhang, W., Tench, C. R., & Gran, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172415 · Cited by 118
Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis
van Horssen, J., van der Pol, S. M. A., Nijland, P. G., Amor, S., & Perron, H. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.04.006 · Cited by 101
Self-citationDuperray, A., Barbe, D., Raguénez, G., Weksler, B. B., Romero, I. A., Couraud, P., Perron, H., & Marche, P. N. (2015) · International Immunology · doi:10.1093/intimm/dxv025 · Cited by 98
Self-citationPushing Forward: Remyelination as the New Frontier in CNS Diseases
Kremer, D., Göttle, P., Hartung, H., & Küry, P. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.02.004 · Cited by 92
Self-citationCurtin, F., Perron, H., Kromminga, A., Porchet, H. C., & Lang, A. B. (2014) · mAbs · doi:10.4161/19420862.2014.985021 · Cited by 89
Self-citationHartung, H.-P., Derfuss, T., Cree, B., Sormani, M. P., Selmaj, K. W., Stutters, J., Prados, F., MacManus, D. G., Schneble, H., Lambert, E., et al. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211024997 · Cited by 88
Self-citationGrandi, N., & Tramontano, E. (2017) · Viruses · doi:10.3390/v9070162 · Cited by 90
An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes
Levet, S., Médina, J., Joanou, J., Demolder, A., Queruel, N., reant, K., Normand, M., Seffals, M., Dimier, J., Germi, R., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.94387 · Cited by 85
Self-citationWu, M., Xu, L., Wang, Y., Zhou, N., Zhen, F., Zhang, Y., Qu, X., Fan, H., Liu, S., Chen, Y., et al. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.09.014 · Cited by 84
Gröger, V., & Cynis, H. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00265 · Cited by 74
Madeira, A., Burgelin, I., Perron, H., Curtin, F., Lang, A. B., & Faucard, R. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.12.006 · Cited by 79
Self-citationPromoting remyelination in multiple sclerosis: Current drugs and future prospects
Kremer, D., Küry, P., & Dutta, R. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514566419 · Cited by 81
Self-citationKhorshidahmad, T., Acosta, C., Cortes, C., Lakowski, T. M., Gangadaran, S., & Namaka, M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9074-1 · Cited by 72
Schmitt, K., Richter, C., Backes, C., Meese, E. U., Ruprecht, K., & Mayer, J. M. (2013) · Journal of Virology · doi:10.1128/jvi.02388-13 · Cited by 73
Human Endogenous Retroviruses and Type 1 Diabetes
Levet, S., Charvet, B., Bertin, A., Deschaumes, A., Perron, H., & Hober, D. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1256-9 · Cited by 74
Self-citationThe Role of Herpes Simplex Virus Type 1 Infection in Demyelination of the Central Nervous System
Bello‐Morales, R., Andreu, S., & López‐Guerrero, J. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145026 · Cited by 74
Repetitive elements in aging and neurodegeneration
Copley, K. E., & Shorter, J. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.02.008 · Cited by 70
Endogenous Retroviruses as Modulators of Innate Immunity
Russ, E. U., & Iordanskiy, S. (2023) · Pathogens · doi:10.3390/pathogens12020162 · Cited by 74
The Role of Oligodendroglial Dysfunction in Amyotrophic Lateral Sclerosis
Nonneman, A., Robberecht, W., & Bosch, L. V. D. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.21 · Cited by 76
Kremer, D., Förster, M., Schichel, T., Göttle, P., Hartung, H., Perron, H., & Küry, P. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514560926 · Cited by 68
Self-citationDerfuss, T. J., Curtin, F., Guebelin, C., Bridel, C., Rasenack, M., Matthey, A., Pasquier, R. D., Schluep, M., Desmeules, J. A., Lang, A. B., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514554052 · Cited by 65
Self-citationWang, X., Huang, J., & Zhu, F. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00422 · Cited by 68
Human endogenous retroviruses in neurologic disease
Christensen, T. (2016) · Apmis · doi:10.1111/apm.12486 · Cited by 62
Epstein–Barr virus and multiple sclerosis. From evidence to therapeutic strategies
Menéndez, S. F., Fernández-Morán, M., Fernández‐Vega, I., Pérez-Álvarez, Á. I., & Villafani, J. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.01.013 · Cited by 68
Milo, R., Korczyn, A. D., Manouchehri, N., & Stüve, O. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519886943 · Cited by 61
Switching Sides: How Endogenous Retroviruses Protect Us from Viral Infections
Badarinarayan, S. S., & Sauter, D. (2021) · Journal of Virology · doi:10.1128/jvi.02299-20 · Cited by 66
Current advancements in promoting remyelination in multiple sclerosis
Kremer, D., Akkermann, R., Küry, P., & Dutta, R. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518800827 · Cited by 62
Self-citationCharvet, B., Reynaud, J. M., Gourru-Lesimple, G., Perron, H., Marche, P. N., & Horvat, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02803 · Cited by 56
Self-citationDo Human Endogenous Retroviruses Contribute to Multiple Sclerosis, and if So, How?
Morris, G., Maes, M. H. J., Murdjeva, M., & Puri, B. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1255-x · Cited by 60
Contribution of Syncytins and Other Endogenous Retroviral Envelopes to Human Placenta Pathologies
Bolze, P., Mommert, M., & Mallet, F. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.005 · Cited by 58
Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective
Jakimovski, D., Weinstock‐Guttman, B., Ramanathan, M. K., Dwyer, M. G., & Zivadinov, R. (2020) · Vaccines · doi:10.3390/vaccines8010050 · Cited by 53
Charvet, B., Brunel, J., Pierquin, J., Iampietro, M., Décimo, D., Queruel, N., Lucas, A., Encabo-Berzosa, M. D. M., Arenaz, I., Pérez-Marmolejo, T., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106604 · Cited by 55
Self-citationMontojo, M. G., Rodríguez‐Martín, E., Ramos‐Mozo, P., Ortega‐Madueño, I., Domínguez‐Mozo, M. I., Arias-Leal, A. M., García‐Martínez, M. Á., Casanova, I., Galán, V., Arroyo, R., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.201948423 · Cited by 51
Human Endogenous Retrovirus as Therapeutic Targets in Neurologic Disease
Giménez-Orenga, K., Perron, H., & Oltra, E. (2021) · Pharmaceuticals · doi:10.3390/ph14060495 · Cited by 50
Self-citationDerfuss, T. J., Curtin, F., Guebelin, C., Bridel, C., Rasenack, M., Matthey, A., Pasquier, R. D., Schluep, M., Desmeules, J. A., Lang, A. B., et al. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.05.019 · Cited by 48
Self-citationViruses and Endogenous Retroviruses as Roots for Neuroinflammation and Neurodegenerative Diseases
Römer, C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.648629 · Cited by 48
Faucard, R., Madeira, A., Gehin, N., Authier, F., Panaite, P., Lesage, C., Burgelin, I., Bertel, M., Bernard, C., Curtin, F., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.03.001 · Cited by 45
Self-citationGruchot, J., Herrero, F., Weber‐Stadlbauer, U., Meyer, U., & Küry, P. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.007 · Cited by 46
Self-citationCurtin, F., Bernard, C., Levet, S., Perron, H., Porchet, H. C., Médina, J., Malpass, S., Lloyd, D., Simpson, R., & on behalf of the RAINBOW‐T1D investigators (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13357 · Cited by 44
Self-citationExosome-enriched fractions from MS B cells induce oligodendrocyte death
Benjamins, J. A., Nedelkoska, L., Touil, H., Stemmer, P. M., Carruthers, N. J., Jena, B. P., Naik, A. R., Bar‐Or, A., & Lisak, R. P. (2019) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000550 · Cited by 43
Morandi, E., Tarlinton, R. E., & Gran, B. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00647 · Cited by 42
Myelin Repair: From Animal Models to Humans
Cayre, M., Falque, M., Mercier, O., Magalon, K., & Durbec, P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.604865 · Cited by 44
Giménez-Orenga, K., Pierquin, J., Brunel, J., Charvet, B., Martín‐Martínez, E., Perron, H., & Oltra, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1020064 · Cited by 39
Self-citationGöttle, P., Förster, M., Gruchot, J., Kremer, D., Hartung, H. P., Perron, H., & Küry, P. (2018) · Glia · doi:10.1002/glia.23535 · Cited by 38
Self-citationEndogenous Retroviruses in Nervous System Disorders
Gröger, V., Emmer, A., Staege, M. S., & Cynis, H. (2021) · Pharmaceuticals · doi:10.3390/ph14010070 · Cited by 39
Charvet, B., Pierquin, J., Brunel, J., Gorter, R. P., Quétard, C., Horvat, B., Amor, S., Portoukalian, J., & Perron, H. (2021) · Virologica Sinica · doi:10.1007/s12250-021-00372-0 · Cited by 39
Self-citationRemyelination in multiple sclerosis: from concept to clinical trials
Kremer, D., Göttle, P., Flores-Rivera, J. D. J., Hartung, H., & Küry, P. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000692 · Cited by 38
Self-citationMorandi, E., Tănăsescu, R., Tarlinton, R. E., Constantin‐Teodosiu, D., & Gran, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03092 · Cited by 35
The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis
Diebold, M., & Derfuss, T. J. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419833574 · Cited by 35
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis
Emmer, A., Staege, M. S., & Kornhuber, M. E. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0100-7 · Cited by 34
The roles played by TLR4 in the pathogenesis of multiple sclerosis; A systematic review article
Manjili, F. A., Yousefi‐Ahmadipour, A., & Arababadi, M. K. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.02.004 · Cited by 34
Wang, X., Wu, X., Huang, J., Li, H., Yan, Q., & Zhu, F. (2021) · Archives of Virology · doi:10.1007/s00705-020-04933-8 · Cited by 35
Gruchot, J., Lewen, I., Dietrich, M., Reiche, L., Sindi, M., Hecker, C., Herrero, F., Charvet, B., Weber‐Stadlbauer, U., Hartung, H., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2308187120 · Cited by 34
Self-citationHSV-1 and Endogenous Retroviruses as Risk Factors in Demyelination
Bello‐Morales, R., Andreu, S., Ripa, I., & López‐Guerrero, J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115738 · Cited by 31
Arru, G., Sechi, E., Mariotto, S., Zarbo, I. R., Ferrari, S., Gajofatto, A., Monaco, S., Deiana, G. A., Bo, M., Sechi, L. A., et al. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577110 · Cited by 30
Prozorovski, T., Ingwersen, J., Lukas, D., Göttle, P., Koop, B. E., Graf, J., Schneider, R., Franke, K., Schumacher, S., Britsch, S., et al. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.007 · Cited by 30
Self-citationHerpesviruses and the hidden links to Multiple Sclerosis neuropathology
Jakhmola, S., Upadhyay, A., Jain, K., Mishra, A., & Jha, H. C. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577636 · Cited by 30
Morris, G., Berk, M., Walder, K. R., & Maes, M. H. J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9262-7 · Cited by 30
Neural Cell Responses Upon Exposure to Human Endogenous Retroviruses
Gruchot, J., Kremer, D., & Küry, P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00655 · Cited by 26
Self-citationPosso‐Osorio, I., Tobón, G. J., & Cañas, C. A. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100137 · Cited by 29
Association between human herpesvirus & human endogenous retrovirus and MS onset & progression
Tao, C., Simpson, S., Taylor, B. V., & van der Mei, I. A. F. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.11.060 · Cited by 27
Kolahdouzan, M., Futhey, N. C., Kieran, N. W., & Healy, L. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01657 · Cited by 26
Tam, O. H., Rozhkov, N. V., Shaw, R., Kim, D., Hubbard, I., Fennessey, S., Propp, N., Fagegaltier, D., Ostrow, L. W., Phatnani, H. P., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/574509 · Cited by 25
Transcriptional Regulation of Endogenous Retroviruses and Their Misregulation in Human Diseases
Zhang, Q., Pan, J., Cong, Y., & Mao, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710112 · Cited by 25
Human Endogenous Retroviruses in Neurodegenerative Diseases
Adler, G. L., Le, K., Fu, Y., & Kim, W. S. (2024) · Genes · doi:10.3390/genes15060745 · Cited by 25
CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation
Kremer, D., Cui, Q., Göttle, P., Kuhlmann, T., Hartung, H., Antel, J. P., & Küry, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146503 · Cited by 28
Self-citationCurtin, F., Vidal, V., Bernard, C., Kromminga, A., Lang, A. B., & Porchet, H. C. (2016) · mAbs · doi:10.1080/19420862.2016.1168956 · Cited by 24
Self-citationAn unmet clinical need: roads to remyelination in MS
Göttle, P., Förster, M., Weyers, V., Küry, P., Rejdak, K., Hartung, H., & Kremer, D. (2019) · Neurological Research and Practice · doi:10.1186/s42466-019-0026-0 · Cited by 24
Self-citationHuman endogenous retroviruses in the aetiology of MS
Christensen, T. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12836 · Cited by 21
The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis
Giovannoni, G., James, L. K., Adeniran, A. A., Gold, J., Young, L. S., Selwood, D. L., Baker, D., & Dobson, R. (2025) · Brain · doi:10.1093/brain/awaf170 · Cited by 23
Latifi, T., Zebardast, A., & Marashi, S. M. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103318 · Cited by 20
Evolutionary Medicine of Retroviruses in the Human Genome
Katsura, Y., & Asai, S. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.09.007 · Cited by 19
Retroviral envelope proteins: Involvement in neuropathogenesis
Hansen, D. T., Petersen, T., & Christensen, T. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.07.027 · Cited by 20
Curtin, F., Perron, H., Faucard, R., Porchet, H. C., & Lang, A. B. (2015) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-015-0166-z · Cited by 18
Self-citationImmunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS
Zimmermann, M., Sanderson, N., Rasenack, M., Lalive, P. H., Lang, A. B., Curtin, F., Lindberg, R. L. P., Kappos, L., & Derfuss, T. J. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000144 · Cited by 18
The Neuroimmunology of Multiple Sclerosis: Fictions and Facts
Pachner, A. R. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.796378 · Cited by 19
Human endogenous retroviruses and multiple sclerosis: Causation, association, or after-effect?
Morandi, E., Tarlinton, R. E., Tănăsescu, R., & Gran, B. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517704711 · Cited by 20
On the origin of a pathogenic HERV-W envelope protein present in multiple sclerosis lesions
Ruprecht, K., & Mayer, J. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911703116 · Cited by 17
Infections and Multiple Sclerosis: From the World to Sardinia, From Sardinia to the World
Frau, J., Coghe, G., Lorefice, L., Fenu, G., & Cocco, E. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.728677 · Cited by 16
Curtin, F., Porchet, H. C., Glanzman, R., Schneble, H. M., Vidal, V., Audoli-Inthavong, M.-L., Lambert, E., & Hartung, H. P. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.07.002 · Cited by 16
Self-citationEndogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model
Censi, S. T., Mariani‐Costantini, R., Granzotto, A., Tomassini, V., & Sensi, S. L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102392 · Cited by 16
Schroeter, C. B., Huntemann, N., Böck, S., Nelke, C., Kremer, D., Pfeffer, K., Meuth, S. G., & Ruck, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.747143 · Cited by 16
Self-citationSiponimod Modulates the Reaction of Microglial Cells to Pro-Inflammatory Stimulation
Gruchot, J., Lein, F., Lewen, I., Reiche, L., Weyers, V., Petzsch, P., Göttle, P., Köhrer, K., Hartung, H., Küry, P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113278 · Cited by 14
Self-citationTamouza, R., Meyer, U., Lucas, A., Richard, J., Nkam, I., Pinot, A., Djonouma, N., Boukouaci, W., Charvet, B., Pierquin, J., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02575-3 · Cited by 14
Self-citationRecruitment of endogenous CNS stem cells for regeneration in demyelinating disease
Murphy, N. A., & Franklin, R. J. M. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2016.12.013 · Cited by 14
Systems Biology to Understand and Regulate Human Retroviral Proinflammatory Response
Helmy, M., & Selvarajoo, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.736349 · Cited by 14
Porchet, H. C., Vidal, V., Kornmann, G., Malpass, S., & Curtin, F. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.05.020 · Cited by 14
Metadata
- Authors
- Kremer, D., Schichel, T., Förster, M., Tzekova, N., Bernard, C., van der Valk, P., van Horssen, J., Hartung, H., Perron, H., & Küry, P.
- Affiliations
- Heinrich Heine University Düsseldorf (DE)
- GeNeuro Geneva Switzerland
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Küry, Patrick
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2013-09-16
- Volume
- 74
- Issue
- 5
- Pages
- 721-732
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2103327619
- Cited by
- 178
- References
- 50
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 13 · 2023: 12 · 2022: 12 · 2021: 23 · 2020: 8 · 2019: 25 · 2018: 16 · 2017: 15 · 2016: 16 · 2015: 13 · 2014: 8 · 2013: 2
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Rose Foundation for Communities and the Environment
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- cell differentiation, remyelination, TLR4, multiple sclerosis, nitrosative stress, inducible nitric oxide synthase, nitrotyrosine, inflammatory cytokines, central nervous system injury
- MeSH terms
- Animals, Cell Differentiation, Cells, Cultured, Humans, Myelin Sheath, Oligodendroglia, Pregnancy Proteins, Gene Products, env, Toll-Like Receptor 4, Rats, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review